4
Changes in Ownership
HAEMONETICS CORP Filed Acc 0001127602-21-017682
EVP, Chief Technology Officer sold 92 shares at $55.19 ($5,077)
- EVP, Chief Technology Officer acquired 10,605 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Lingamneni Anila · EVP, Chief Technology Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-18 | Grant or award : show line 1 in the form | +3,535 | 7,224 | D | ||
| 2021-05-18 | Grant or award : show line 2 in the form | +7,070 | 14,294 | D | ||
| 2021-05-19 | Sale : show line 3 in the form | −92 | $55.19 | $5,077 | 14,202 | D |
| Open-market sales · 92 sh · avg $55.19 · $5,077 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-05-18 | Grant or award : show line 4 in the form Non-qualified Stock Option (Right to Buy) | +9,564 | 9,564 | D |
Loading xslF345X03/form4.xml…